Cytokine release kinetics of concentrated growth factors in different scaffolds

2018 ◽  
Vol 23 (4) ◽  
pp. 1663-1671 ◽  
Author(s):  
Min Yu ◽  
Xiujing Wang ◽  
Yan Liu ◽  
Jing Qiao
2013 ◽  
Vol 195 (5) ◽  
pp. 461-466 ◽  
Author(s):  
Eduardo Anitua ◽  
Mari Mar Zalduendo ◽  
Mohammad Hamdan Alkhraisat ◽  
Gorka Orive

2020 ◽  
Vol 21 (2) ◽  
pp. 624 ◽  
Author(s):  
Cristina Del Amo ◽  
Arantza Perez-Valle ◽  
Elena Perez-Zabala ◽  
Karmele Perez-del-Pecho ◽  
Ainara Larrazabal ◽  
...  

The use of platelet-rich fibrin (PRF) is investigated in ulcer management because it provides a healing milieu rich in growth factors and cytokines. Although crucial, the relevance of secondary dressings is under-researched and no data support the use of any particular dressing in preference to another. We assessed the properties of different dressing categories, including alginates, hydrocolloids, foams, hydrofibers, films, meshes and gauzes, in terms of affinity for PRF, releasate management (retention/extrusion) and the kinetics of cytokine release as well as the influence of each combination product, [PRF + dressing], on dermal cell behaviour, aiming to provide useful information for choosing the most adequate dressing for each particular patient. Active dressings including alginates, hydrofibers, foams and hydrocolloids blend with PRF, creating a diverse combination of products with different performances. Alginate and hydrofiber showed the highest affinity but moderate retention of releasate, without interfering with cell functions. Instead, the foam sequestered the releasate and hindered the release of growth factors, thereby compromising cell activities. Film and mesh presented very poor releasate retention and performed similarly to PRF by itself. Affinity index and releasate management explained 79% of platelet-derived growth factor (PDGF-BB) concentration variability, p < 0.001. Cell proliferation depended on the ability of the combination product to retain/release supernatant, PDGF-BB concentration and cell adhesion R2 = 0.91, p = 0.014.


2016 ◽  
Vol 696 ◽  
pp. 245-249
Author(s):  
Ahmed El-Ghannam

Silica-calcium-phosphate composite (SCPC) is a drug delivery platform that has successfully demonstrated the ability to bind and release several therapeutics including antibiotics, peptides, anticancer drugs, and growth factors. It has successfully demonstrated a unique capacity for bone regeneration. The present studies address the effect of the phosphate and silicate functional groups on drug binding and controlled release kinetics of Cisplatin (Cis). Moreover, the roles of ceramic composition and resorbability on rhBMP2 release kinetics and bone regeneration in a critical size calvarial defect in rabbit is presented.


2019 ◽  
Vol 100 ◽  
pp. 57-68 ◽  
Author(s):  
Jordi Caballé-Serrano ◽  
Yusra Abdeslam-Mohamed ◽  
Antonio Munar-Frau ◽  
Masako Fujioka-Kobayashi ◽  
Federico Hernández-Alfaro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document